Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Ritterman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Rhode Island Medical Journal (2013)|May 4, 2013
Management of the 'young' patient with hip diseaseScott A Ritterman, Lee E Rubin
Rhode Island Medical Journal (2013)|May 4, 2013
Current thoughts on ankle arthritisScott A Ritterman, Todd A Fellars, Christopher W Digiovanni
The Journal of the American Academy of Orthopaedic Surgeons|April 29, 2015
Paralytic ileus in the orthopaedic patientAlan H Daniels, Scott A Ritterman, Lee E Rubin
American Journal of Orthopedics (Belle Mead, N.J.)|November 27, 2013
Primary knee arthrodesis for severe crystalline arthropathyBryan G Vopat, Scott A Ritterman, Stephen Kayiaros, et al.
JBJS Reviews|August 9, 2016
Hip Resection ArthroplastyLee E Rubin, Kenneth T Murgo, Scott A Ritterman, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|December 15, 2015
Effects of Tranexamic Acid Cytotoxicity on In Vitro ChondrocytesJohn R Tuttle, Peter R Feltman, Scott A Ritterman, et al.
Pediatric Emergency Care|July 26, 2014
J-splint use for temporizing management of pediatric femur fractures: a review of 18 casesScott A Ritterman, Alan H Daniels, Patrick M Kane, et al.
The Journal of Arthroplasty|May 18, 2017
Intraoperative Femur Fracture Risk During Primary Direct Anterior Approach Cementless Total Hip Arthroplasty With and Without a Fracture TableEric M Cohen, Joshua J Vaughn, Scott A Ritterman, et al.
The Journal of Arthroplasty|March 18, 2014
Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplastyJohn R Tuttle, Scott A Ritterman, Dale B Cassidy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Rhode Island Medical Journal (2013)|May 4, 2013
Management of the 'young' patient with hip diseaseScott A Ritterman, Lee E Rubin
Rhode Island Medical Journal (2013)|May 4, 2013
Current thoughts on ankle arthritisScott A Ritterman, Todd A Fellars, Christopher W Digiovanni
The Journal of the American Academy of Orthopaedic Surgeons|April 29, 2015
Paralytic ileus in the orthopaedic patientAlan H Daniels, Scott A Ritterman, Lee E Rubin
American Journal of Orthopedics (Belle Mead, N.J.)|November 27, 2013
Primary knee arthrodesis for severe crystalline arthropathyBryan G Vopat, Scott A Ritterman, Stephen Kayiaros, et al.
JBJS Reviews|August 9, 2016
Hip Resection ArthroplastyLee E Rubin, Kenneth T Murgo, Scott A Ritterman, et al.
American Journal of Orthopedics (Belle Mead, N.J.)|December 15, 2015
Effects of Tranexamic Acid Cytotoxicity on In Vitro ChondrocytesJohn R Tuttle, Peter R Feltman, Scott A Ritterman, et al.
Pediatric Emergency Care|July 26, 2014
J-splint use for temporizing management of pediatric femur fractures: a review of 18 casesScott A Ritterman, Alan H Daniels, Patrick M Kane, et al.
The Journal of Arthroplasty|May 18, 2017
Intraoperative Femur Fracture Risk During Primary Direct Anterior Approach Cementless Total Hip Arthroplasty With and Without a Fracture TableEric M Cohen, Joshua J Vaughn, Scott A Ritterman, et al.
The Journal of Arthroplasty|March 18, 2014
Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplastyJohn R Tuttle, Scott A Ritterman, Dale B Cassidy, et al.
Pageof 1